1-5 of 5
Francis Y. Lee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Gamma Secretase Inhibition by BMS-906024 Enhances Efficacy of Paclitaxel in Lung Adenocarcinoma

Katherine M. Morgan, Bruce S. Fischer, Francis Y. Lee, Jamie J. Shah, Joseph R. Bertino, Jeffrey Rosenfeld, Amartya Singh, Hossein Khiabanian, Sharon R. Pine
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (12): 2759–2769.
https://doi.org/10.1158/1535-7163.MCT-17-0439
Published: 03 December 2017
View article titled, Gamma Secretase Inhibition by BMS-906024 Enhances Efficacy of Paclitaxel in Lung Adenocarcinoma
Open the PDF for Gamma Secretase Inhibition by BMS-906024 Enhances Efficacy of Paclitaxel in Lung Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract B195: Synergy between ixabepilone (Ixa) and trastuzumab (TZ): Investigation of the role of microtubule‐associated protein (MAP‐tau) and III tubulin (βIII) in HER2‐positive (HER2+) breast cancer (BC)

Francis Y. Lee, Mei‐Li Wen, Shirin Khambata‐Ford, Craig Fairchild, Susan Galbraith, Christine E. Horak
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): B195.
https://doi.org/10.1158/1535-7163.TARG-09-B195
Published: 10 December 2009
View article titled, Abstract B195: Synergy between ixabepilone (Ixa) and trastuzumab (TZ): Investigation of the role of microtubule‐associated protein (MAP‐tau) and III tubulin (βIII) in HER2‐positive (HER2+) breast cancer (BC)
Journal Articles

Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells

Sangkil Nam, Ann Williams, Adina Vultur, Alan List, Kapil Bhalla, David Smith, Francis Y. Lee, Richard Jove
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (4): 1400–1405.
https://doi.org/10.1158/1535-7163.MCT-06-0446
Published: 12 April 2007
View article titled, Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells
Open the PDF for Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells in another window
Journal Articles

Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib

Alan Serrels, Iain R.J. Macpherson, T.R. Jeffry Evans, Francis Y. Lee, Edwin A. Clark, Owen J. Sansom, Gabrielle H. Ashton, Margaret C. Frame, Valerie G. Brunton
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (12): 3014–3022.
https://doi.org/10.1158/1535-7163.MCT-06-0382
Published: 15 December 2006
View article titled, Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib
Open the PDF for Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib in another window
Journal Articles

Constitutively active receptor tyrosine kinases as oncogenes in preclinical models for cancer therapeutics

Kristen A. Kellar, Matthew V. Lorenzi, Ching Ping Ho, Dan You, Mei-Li Wen, Rolf P. Ryseck, Simone Oppenheimer, Brian E. Fink, Gregory D. Vite, Bruce R. Rowley, Chiang Yu, David K. Bol, Francis Y. Lee, Tai W. Wong
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (6): 1571–1576.
https://doi.org/10.1158/1535-7163.MCT-06-0078
Published: 03 July 2006
View article titled, Constitutively active receptor tyrosine kinases as oncogenes in preclinical models for cancer therapeutics
Open the PDF for Constitutively active receptor tyrosine kinases as oncogenes in preclinical models for cancer therapeutics in another window